Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells.

Transl Oncol

Academy of Scientific & Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR), Canal Road, Jammu, Jammu and Kashmir 180001, India. Electronic address:

Published: January 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The last decade has witnessed a substantial expansion in the field of microRNA (miRNA) biology, providing crucial insights into the role of miRNAs in disease pathology, predominantly in cancer progression and its metastatic spread. The discovery of tumor-suppressing miRNAs represents a potential approach for developing novel therapeutics. In this context, through miRNA microarray analysis, we examined the consequences of Prostate apoptosis response-4 (Par-4), a well-established tumor-suppressor, stimulation on expression of different miRNAs in Panc-1 cells. The results strikingly indicated elevated miR-200c levels in these cells upon Par-4 overexpression. Intriguingly, the Reverse Phase Protein Array (RPPA) analysis revealed differentially expressed proteins (DEPs), which overlap between miR200c- and Par-4-transfected cells, highlighting the cross-talks between these pathways. Notably, Phospho-p44/42 MAPK; Bim; Bcl-xL; Rb Phospho-Ser807, Ser811; Akt Phospho-Ser473; Smad1/5 Phospho-Ser463/Ser465 and Zyxin scored the most significant DEPs among the two data sets. Furthermore, the GFP-Par-4-transfected cells depicted an impeded expression of critical mesenchymal markers viz. TGF-β1, TGF-β2, ZEB-1, and Twist-1, concomitant with augmented miR-200c and E-cadherin levels. Strikingly, while Par-4 overexpression halted ZEB-1 at the transcriptional level; contrarily, silencing of endogenous Par-4 by siRNA robustly augmented the Epithelial-mesenchymal transition (EMT) markers, along with declining miR-200c levels. The pharmacological Par-4-inducer, NGD16, triggered Par-4 expression which corresponded with increased miR-200c resulting in the ZEB-1 downregulation. Noteworthily, tumor samples obtained from the syngenic mouse pancreatic cancer model revealed elevated miR-200c levels in the NGD16-treated mice that positively correlated with the Par-4 and E-cadherin levels in vivo; while a negative correlation was evident with ZEB-1 and Vimentin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557890PMC
http://dx.doi.org/10.1016/j.tranon.2020.100879DOI Listing

Publication Analysis

Top Keywords

mir-200c levels
12
pancreatic cancer
8
elevated mir-200c
8
par-4 overexpression
8
e-cadherin levels
8
par-4
7
mir-200c
6
cells
5
levels
5
overlapping targets
4

Similar Publications

Long non-coding RNA MALAT1 regulates epithelial-mesenchymal transition (EMT) and metastasis in epithelial ovarian cancer (EOC) through a competing endogenous RNA (ceRNA) mechanism involving miRNA modulation. This study aimed to elucidate the molecular pathway by which MALAT1 influences EMT and metastatic behavior via interaction with miR-200c-3p and SNAI2. MALAT1 expression was genetically manipulated in the EOC cell line SK-OV-3 by either overexpression or knockdown.

View Article and Find Full Text PDF

ObjectiveDNA methylation is a key regulator of gene expression and plays a crucial role in cancer development. However, the mechanisms driving gene-specific methylation remain unclear. This study investigates the role of microRNAs (miRNAs) in regulating promoter methylation of specific genes, aiming to uncover miRNA-driven modulation of gene methylation in cancer.

View Article and Find Full Text PDF

Background: Some microRNAs (miRNAs) may have potential as biomarkers for axillary lymph node metastasis (ALNM) in breast cancer.

Methods: PubMed was systematically searched from its inception to October 2023 using the search term 'miRNA and breast cancer lymph node metastasis' to identify miRNAs reported in three or more relevant publications. Each qualifying miRNA was then paired with 'breast cancer' as search terms across four databases (PubMed, Embase, Web of Science, and Cochrane Library) covering the same time span.

View Article and Find Full Text PDF

Mitigates Pulpitis and Promotes Dentin Regeneration.

Int J Mol Sci

July 2025

Iowa Institute for Oral Health Research, College of Dentistry, the University of Iowa, Iowa City, IA 52242, USA.

enhances osteogenesis, modulates inflammation, and participates in dentin development. This study was to investigate the beneficial potential of in vital pulp therapy (VPT) by mitigating pulpitis and promoting dentin regeneration. We explored the variations in inflamed pulp tissues from patients with symptomatic irreversible pulpitis and primary human dental pulp-derived cells (DPCs) challenged with lipopolysaccharide (-LPS).

View Article and Find Full Text PDF

Elevating prostate cancer diagnostics through extracellular vesicle miRNAs.

Gene

September 2025

Department for BioMedical Research, Urology Research Laboratory, University of Bern, Bern, Switzerland; Translational Organoid Models, Department for BioMedical Research, University of Bern, Bern, Switzerland; Department of Urology, Inselspital, Bern University Hospital, Bern, Switzerland.

In this edition of Gene's 'Editor's Corner,' we highlight the emerging potential of extracellular vesicle-derived miRNAs as valuable biomarkers for prostate cancer diagnostics. In the recent issue of Gene (Gene 939, 2025, 149186), Nobrega et al. 1 present a compelling study that advances the field of liquid biopsy by comparing extracellular vesicle-incorporated microRNAs (EV-miRNAs) with cell-free microRNAs (cfmiRNAs) as biomarkers for prostate cancer.

View Article and Find Full Text PDF